State Codes and Statutes

Statutes > Michigan > Chapter-330 > Act-258-of-1974 > 258-1974-7 > Section-330-1719

MENTAL HEALTH CODE (EXCERPT)
Act 258 of 1974

330.1719 Psychotropic drug treatment; duties of prescriber or licensed health professional.

Sec. 719.

Before initiating a course of psychotropic drug treatment for a recipient, the prescriber or a licensed health professional acting under the delegated authority of the prescriber shall do both of the following:

(a) Explain the specific risks and the most common adverse effects that have been associated with that drug.

(b) Provide the individual with a written summary of the most common adverse effects associated with that drug.


History: Add. 1995, Act 290, Eff. Mar. 28, 1996 ;-- Am. 1996, Act 588, Imd. Eff. Jan. 21, 1997

State Codes and Statutes

Statutes > Michigan > Chapter-330 > Act-258-of-1974 > 258-1974-7 > Section-330-1719

MENTAL HEALTH CODE (EXCERPT)
Act 258 of 1974

330.1719 Psychotropic drug treatment; duties of prescriber or licensed health professional.

Sec. 719.

Before initiating a course of psychotropic drug treatment for a recipient, the prescriber or a licensed health professional acting under the delegated authority of the prescriber shall do both of the following:

(a) Explain the specific risks and the most common adverse effects that have been associated with that drug.

(b) Provide the individual with a written summary of the most common adverse effects associated with that drug.


History: Add. 1995, Act 290, Eff. Mar. 28, 1996 ;-- Am. 1996, Act 588, Imd. Eff. Jan. 21, 1997


State Codes and Statutes

State Codes and Statutes

Statutes > Michigan > Chapter-330 > Act-258-of-1974 > 258-1974-7 > Section-330-1719

MENTAL HEALTH CODE (EXCERPT)
Act 258 of 1974

330.1719 Psychotropic drug treatment; duties of prescriber or licensed health professional.

Sec. 719.

Before initiating a course of psychotropic drug treatment for a recipient, the prescriber or a licensed health professional acting under the delegated authority of the prescriber shall do both of the following:

(a) Explain the specific risks and the most common adverse effects that have been associated with that drug.

(b) Provide the individual with a written summary of the most common adverse effects associated with that drug.


History: Add. 1995, Act 290, Eff. Mar. 28, 1996 ;-- Am. 1996, Act 588, Imd. Eff. Jan. 21, 1997